Skip to main content

Aggregator

Association between prescription drugs and all-cause mortality risk in the UK population

8 months 4 weeks ago
Although most drugs currently approved are meant to treat specific diseases or symptoms, it has been hypothesized that some might bear a beneficial effect on lifespan in healthy older individuals, outside of their specific disease indication. Such drugs include, among others, metformin, SGLT2 inhibitors and rapamycin. Since 2006, the UK biobank has recorded prescription medication and mortality data for over 500'000 participants, aged between 40 and 70 years old. In this work, we examined the...
Jonas Morin

Rejuvenation factor PF4: a potential gatekeeper for neurodegenerative diseases

8 months 4 weeks ago
Recently, it is discovered PF4 is a cognitive enhancer that improved the cognitive abilities of younger mice and gave older animals their middle-aged acuity back. PF4 works by reducing inflammation during the aging process. As we all known, aging is undoubtedly the main risk factor of neurodegenerative diseases. Furthermore, inflammation has been extensively investigated and attracted even more interest. Therefore, the aim of the proposal is to highlight the worth of PF4 in inflammaging of...
Fengju Jia

De novo gene synthesis by an antiviral reverse transcriptase

8 months 4 weeks ago
Science, Volume 386, Issue 6717, October 2024.
Stephen Tang, Valentin Conte, Dennis J. Zhang, Rimantė Žedaveinytė, George D. Lampe, Tanner Wiegand, Lauren C. Tang, Megan Wang, Matt W. G. Walker, Jerrin Thomas George, Luke E. Berchowitz, Marko Jovanovic, Samuel H. Sternberg




Relocalizing transcriptional kinases to activate apoptosis

8 months 4 weeks ago
Science, Volume 386, Issue 6717, October 2024.
Roman C. Sarott, Sai Gourisankar, Basel Karim, Sabin Nettles, Haopeng Yang, Brendan G. Dwyer, Juste M. Simanauskaite, Jason Tse, Hind Abuzaid, Andrey Krokhotin, Tinghu Zhang, Stephen M. Hinshaw, Michael R. Green, Gerald R. Crabtree, Nathanael S. Gray